Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vericel Corporation - Common Stock (NQ:VCEL)

36.70 +1.64 (+4.69%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Vericel Corporation - Common Stock

< Previous 1 2 Next >
Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel Reports Second Quarter 2025 Financial Results
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at Multiple Upcoming Investor Conferences
From Vericel Corporation
Via GlobeNewswire
Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
From Vericel Corporation
Via GlobeNewswire
Vericel Reports Third Quarter 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel Announces FDA Approval and Commercial Availability of MACI Arthro
From Vericel Corporation
Via GlobeNewswire
Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel Reports Second Quarter 2024 Financial Results
From Vericel Corporation
Via GlobeNewswire
Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance
From Vericel Corporation
Via GlobeNewswire
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance
From Vericel Corporation
Via GlobeNewswire
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024
From Vericel Corporation
Via GlobeNewswire
Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024
From Vericel Corporation
Via GlobeNewswire
5 medical stocks growing earnings by triple digits
There is a little known way to pick stocks like the pros do, and today's exercise points you to five high-probability winners in a sector that's quickly turning 
Via MarketBeat
Topics Economy
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.